Novo Nordisk Pharmatech is a Manufacturer/Innovator company operating in the pharmaceutical industry.
Novo Nordisk Pharmatech is a leading manufacturer of pharmaceutical ingredients for the pharmaceutical and biopharmaceutical industries. The company specializes in producing pharma-grade quaternary ammonium compounds (Quats) used as APIs and excipients and Recombinant Insulin for use in cell culture media to enhance cell growth and viability, and productivity. Helping the world�s largest pharma and biopharma industries reduce their risk for raw materials by using pharma-grade products with a high level of batch-to-batch consistency.
Company type
Manufacturer/Innovator
Products and services
Biopharmaceuticals, Excipients, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Novo Nordisk Pharmatech on LinkedIn
Address
Novo Nordisk Pharmatech, Kobenhavnsvej 216, Koege, Denmark, 4600
